drugset / Trial / NCT07647107
A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations
Phase 1
Not yet recruiting
60 enrolled
PT Bio Farma
Dr Cipto Mangunkusumo General Hospital · collabFakultas Kedokteran Universitas Indonesia · collab
RandomizedSequentialQuadruple-blindTreatment
Summary
A Phase I, Double-Blind, Randomized, Placebo Controlled Trial to Evaluate Safety and Immunogenicity of Lipovaxin Tuberculosis Vaccine (Bio Farma) in Healthy Populations Aged 18-40 Years in Indonesia
Timeline
- Start
- 2026-08
- Primary completion
- 2027-07
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LipovaxinS4-EAH | Vaccine | 20 ug | Intramuscular |
| Subject | LipovaxinS4-EAH | Vaccine | 25 ug | Intramuscular |